Format

Send to

Choose Destination
Curr Opin Genet Dev. 2007 Feb;17(1):45-51.

The many ways of Wnt in cancer.

Author information

1
Department of Research, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. ppolakis@gene.com

Abstract

More than 20 years ago, the oncogenicity of a Wnt ligand was revealed in a series of experiments originating with random proviral integration in mice. The significance of Wnt signaling in human cancer has since been buttressed by the identification of mutations in genes coding for the Wnt pathway components Axin, APC, and beta-catenin. This review summarizes the reported genetic defects in the Wnt pathway, with an emphasis on their functional contribution to human tumor progression.

PMID:
17208432
DOI:
10.1016/j.gde.2006.12.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center